Envestnet Asset Management Inc Dexcom Inc Transaction History

Envestnet Asset Management Inc

$302 Billion
Q4 2024

A detailed history of Envestnet Asset Management Inc transactions in Dexcom Inc stock. As of the latest transaction made, Envestnet Asset Management Inc holds 584,065 shares of DXCM stock, worth $52.9 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares

584,065

Previous 514,530 13.51%

Holding current value

$52.9 Million

Previous $34.5 Million 31.72%

% of portfolio

0.02%

Previous 0.01%

31 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 12, 2025	BUY	$65.68 - $81.01 $4.57 Million - $5.63 Million	69,535 Added 13.51%	584,065 $45.4 Million
Q3 2024 Nov 06, 2024	SELL	$64.0 - $116.06 $5.43 Million - $9.84 Million	-84,773 Reduced 14.15%	514,530 $34.5 Million
Q2 2024 Aug 08, 2024	BUY	$110.31 - $140.45 $370,200 - $471,350	3,356 Added 0.56%	599,303 $67.9 Million
Q1 2024 May 13, 2024	BUY	$114.22 - $140.1 $6.57 Million - $8.06 Million	57,520 Added 10.68%	595,947 $82.7 Million
Q4 2023 Feb 13, 2024	SELL	$75.49 - $124.16 $8.97 Million - $14.8 Million	-118,807 Reduced 18.08%	538,427 $66.8 Million
Q3 2023 Nov 13, 2023	BUY	$86.06 - $137.93 $6.27 Million - $10 Million	72,850 Added 12.47%	657,234 $61.3 Million
Q2 2023 Aug 04, 2023	SELL	$112.47 - $130.98 $1.68 Million - $1.96 Million	-14,926 Reduced 2.49%	584,384 $75.1 Million
Q1 2023 May 11, 2023	SELL	$104.0 - $122.92 $1.75 Million - $2.07 Million	-16,807 Reduced 2.73%	599,310 $69.6 Million
Q4 2022 Feb 07, 2023	SELL	$84.98 - $122.67 $1.31 Million - $1.89 Million	-15,423 Reduced 2.44%	616,117 $69.8 Million
Q3 2022 Nov 10, 2022	SELL	$76.35 - $94.18 $363,502 - $448,390	-4,761 Reduced 0.75%	631,540 $50.9 Million
Q2 2022 Aug 03, 2022	BUY	$67.99 - $132.89 $32.1 Million - $62.8 Million	472,692 Added 288.92%	636,301 $47.4 Million
Q1 2022 May 04, 2022	BUY	$94.08 - $130.2 $161,911 - $224,074	1,721 Added 1.06%	163,609 $83.7 Million
Q4 2021 Feb 04, 2022	BUY	$129.87 - $162.82 $124,934 - $156,632	962 Added 0.6%	161,888 $86.9 Million
Q3 2021 Oct 07, 2021	BUY	$106.71 - $143.18 $85,154 - $114,257	798 Added 0.5%	160,926 $88 Million
Q2 2021 Aug 04, 2021	BUY	$80.99 - $107.93 $3.05 Million - $4.06 Million	37,654 Added 30.74%	160,128 $68.4 Million
Q1 2021 May 04, 2021	BUY	$84.79 - $104.74 $2.51 Million - $3.1 Million	29,615 Added 31.89%	122,474 $44 Million
Q4 2020 Feb 02, 2021	BUY	$78.0 - $104.5 $1.44 Million - $1.92 Million	18,419 Added 24.74%	92,859 $34.3 Million
Q3 2020 Oct 09, 2020	BUY	$95.51 - $112.95 $908,395 - $1.07 Million	9,511 Added 14.65%	74,440 $30.7 Million
Q2 2020 Jul 08, 2020	BUY	$62.68 - $105.34 $45,380 - $76,266	724 Added 1.13%	64,929 $26.3 Million
Q1 2020 Apr 23, 2020	BUY	$47.79 - $75.63 $173,047 - $273,856	3,621 Added 5.98%	64,205 $17.3 Million
Q4 2019 Feb 11, 2020	BUY	$36.62 - $57.29 $137,398 - $214,952	3,752 Added 6.6%	60,584 $13.3 Million
Q3 2019 Oct 17, 2019	BUY	$35.53 - $43.8 $374,734 - $461,958	10,547 Added 22.79%	56,832 $8.48 Million
Q2 2019 Aug 02, 2019	BUY	$27.84 - $38.92 $323,974 - $452,912	11,637 Added 33.59%	46,285 $6.94 Million
Q1 2019 May 10, 2019	BUY	$28.07 - $38.18 $121,346 - $165,052	4,323 Added 14.26%	34,648 $4.13 Million
Q4 2018 Feb 13, 2019	BUY	$26.99 - $37.37 $818,471 - $1.13 Million	30,325 New	30,325 $3.63 Million
Q3 2018 Nov 14, 2018	SELL	$23.35 - $36.72 $102,973 - $161,935	-4,410 Closed	0 $0
Q2 2018 Aug 10, 2018	BUY	$17.54 - $25.22 $105 - $151	6 Added 0.14%	4,410 $419,000
Q1 2018 May 09, 2018	SELL	$13.06 - $18.54 $16,416 - $23,304	-1,257 Reduced 22.2%	4,404 $327,000
Q4 2017 Feb 20, 2018	SELL	$11.12 - $15.38 $110,443 - $152,754	-9,932 Reduced 63.7%	5,661 $324,000
Q3 2017 Nov 13, 2017	SELL	$11.36 - $18.98 $14,120 - $23,592	-1,243 Reduced 7.38%	15,593 $763,000
Q2 2017 Aug 14, 2017	BUY	N/A	16,836	16,836 $1.23 Million

Others Institutions Holding DXCM

# of Institutions

1,078

Shares Held

351M

Call Options Held

8.45M

Put Options Held

5.75M

View Full List

About DEXCOM INC

Ticker DXCM
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 386,257,984
Market Cap $35B
Description
DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for use by people with diabetes, as well as for use by healthcare providers. Its products include DexCom G6, an integrated CGM ...

More about DXCM

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Envestnet Asset Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Envestnet Asset Management Inc with notifications on news.

Account

Envestnet Asset Management Inc Dexcom Inc Transaction History